BIOGRAPHY
Joel M. Gelfand MD MSCE is the James J. Leyden Endowed Professor of Clinical Investigation, and Professor (with tenure) of Dermatology and Epidemiology, Director (co-founding) of the Center for Clinical Sciences in Dermatology, and Director of the Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania Perelman School of Medicine. He is an internationally recognized expert in psoriasis, epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 330 scientific publications cited over 49,000 times (H index 108). His research program was the first to establish that psoriasis patients have an increased risk of cardiovascular disease and mortality. He conducts patient centered research through the Dermatology Clinical Effectiveness Research Network (DCERN), which he founded in 2009 and involves over 50 dermatology practices in the US. He has received investigator-initiated research grants from NIH, FDA, PCORI, Foundations, and industry. He has given over 10 named lectureships and keynote addresses including the SID ’s Eugene M. Farber lecture and the AAD’s Marion B. Sulzberger lecture. He is the recipient of the National Psoriasis Foundation’s 2025 Lifetime Achievement Award, the American College of Epidemiology 2023 Outstanding Contributions Award, the American Skin Association’s Psoriasis Achievement Award, and the American Dermatoepidemiology Network’s Founders Award. He is an elected member of the American Society for Clinical Investigation and the American Dermatological Association and is listed in America’s Best Dermatologists (Newsweek Magazine). He is a member of the Board of Directors for the International Psoriasis Council where he serves as treasurer.
SESSIONS
DISCLOSURES
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);